Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methylamine | HCID 6329 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Triphosgene | HCID 94429 | — |
| Reactant | HCID 66589022 | HCID 66589022 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 25262026 | HCID 25262026 | — |
Reaction Steps
A solution of 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline (110 mg, 0.22 mmol) in a mixture of dichloromethane (10 mL) and tetrahydrofuran (10 mL) was treated with triethylamine (0.10 mL), followed by triphosgene (100 mg, 0.34 mmol). After the passage of five minutes, 2.0 M methylamine solution in tetrahydrofuran (10 mL) was added. The mixture was concentrated to dryness under reduced pressure. The resultant residue was purified via reverse-phase high performance liquid chromatography using a Phenomenex Prodigy 21 mm×250 mm column, running a gradient elution of 10% acetonitrile/90% of 0.1% aqueous trifluoroacetic acid to 95% acetonitrile. After the concentration of fractions under reduced pressure, 1-methyl-3-(4-{4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl}phenyl)urea was obtained. MS (ES+): 545.2 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08129371B2 |
|---|
| Source dataset | uspto-grants-2012_03 |
|---|
| ORD ID | ord-e187c879861546a498f5b99241f95765 |
|---|
| Source note | uspto-grants-2012_03 |
|---|